The DermaSensor™ device is a handheld, non-invasive device that uses light, through a technology called elastic scattering spectroscopy (ESS) and artificial intelligence to evaluate skin lesions in a matter of seconds. The internal processor analyzes the light reflected from a lesion to objectively help trained healthcare professionals evaluate whether a skin lesion is cancerous through its “Higher Risk / Lower Risk” output.
How the Technology Works
- The tip of the DermaSensor™ reflects and records quick bursts of light off the lesion’s cellular structures.
- The light is analyzed by the built-in computer to distinguish different types of malignant skin lesions (including melanomas, squamous cell carcinomas, and basal cell carcinomas) from benign skin lesions.
- By examining the difference in light scattering, DermaSensor™ determines if the skin lesion is at “Higher Risk” or “Lower Risk,” of malignancy with an instantaneous and actionable output.